Tag: Art
-
Picture of health: Going to art galleries can boost wellbeing, study finds
Art as a prescription for wellbeing An unexpected source of wellness may be closer than you think: original works of art in a gallery. A pioneering study led by King’s College London has found that simply viewing masterpieces can calm the body while uplifting the mind. The findings suggest that the experience of looking at…
-
Low HBV Reactivation Risk After Tenofovir Withdrawal in People with HIV: New EACS 2025 Findings
Background: Tenofovir and HBV in HIV Care Tenofovir has been a cornerstone of antiretroviral therapy (ART) for people living with HIV, partly because it also provides activity against hepatitis B virus (HBV). For patients with past HBV exposure who are virologically suppressed, clinicians have explored strategies to reduce long-term drug toxicity—especially renal and bone side…
-
Low Risk of HBV Reactivation After Tenofovir Withdrawal in People With HIV
New evidence supports safety of tenofovir-sparing ART in HBV-immune people with HIV Emerging data presented at the 2025 European AIDS Clinical Society (EACS) Congress suggest that stopping tenofovir in people with HIV who have prior hepatitis B exposure poses a very small risk of hepatitis B virus (HBV) reactivation. The findings come from the Swiss…
-
Immunotherapy for HIV: Early PD-1 Treatment Shows Potential for Drug-Free Viral Control
Overview: A new immunotherapy approach in HIV Researchers report promising safety data from the first-in-human trial of an anti-PD-1 antibody, budigalimab, in people living with HIV. The study, published in Nature Medicine, explored whether a cancer immunotherapy could be used at low doses to augment the immune system’s ability to control HIV without daily antiretroviral…
-
Immunotherapy Trial: PD-1 Inhibitor Budigalimab Shows Potential for Drug-Free HIV Control
New Immunotherapy Approach Sparks Hope for HIV Management Researchers have taken a bold step in the hunt for HIV strategies that could reduce or even eliminate the need for daily antiretroviral therapy (ART). A first-in-human, randomized, placebo-controlled Phase 1b trial published in Nature Medicine explored budigalimab, a monoclonal antibody that targets the PD-1 protein, a…
-
Why Do Young Filipinos Continue to Test Positive for HIV?
Rising HIV Rates in the Philippines: A Complex Landscape The Philippines has witnessed a dramatic surge in HIV cases over the past decade, despite regional declines elsewhere in Asia. Between 2010 and 2024, the country reported a roughly 550% increase in new infections, prompting renewed calls to treat HIV as a public health emergency. The…
-
Why Do Young Filipinos Continue to Test Positive for HIV? Understanding the Rising Trend
Understanding the Surge: HIV Trends Among Filipino Youth The Philippines has seen a troubling rise in new HIV infections among the young, with recent data showing thousands of new cases each quarter. While some neighboring countries managed to slow the epidemic, the Philippines recorded a sustained increase, prompting calls for a stronger public health response.…
-
HIV in the Philippines: Why Are Young Filipinos Testing Positive?
Overview: A Growing Challenge Among Filipino Youth The Philippines has earned a troubling distinction as one of Asia and the Pacific’s fastest-rising HIV-affected countries. From 2010 to 2024, the country reported a dramatic surge in new infections, with the latest data showing a continued upward trajectory into 2025. While regional peers have reduced new cases,…
-
Behavioral HIV Serosurvey: Clustering of Risk Factors Sustains Transmission in Rural KwaZulu-Natal
Overview A population-based cross-sectional survey conducted in 2018 in Eshowe/Mbongolwane, KwaZulu-Natal, reveals that while new HIV infections have declined in high-prevalence settings, a subset of HIV-positive individuals with high-risk sexual behavior and limited ART engagement continues to sustain transmission. Focusing on adults aged 15–59, the study analyzes HIV awareness, ART uptake, viral suppression, and sexual…
-
Behavioral HIV-serosurvey in rural KwaZulu-Natal highlights clusters of risk factors sustaining HIV transmission
Overview: Why this survey matters Despite notable declines in new HIV infections across many high-prevalence countries, unsuppressed individuals engaging in high-risk sexual practices continue to drive transmission. A population-based, cross-sectional study conducted in KwaZulu-Natal, South Africa, focused on HIV-positive adults aged 15–59 to identify age-gender groups most responsible for sustaining transmission. Conducted from August to…